CME Group Inc. $CME Stock Holdings Boosted by Intrua Financial LLC

13 Sep 2025, 10:28 by Michael Walen · The Markets Daily

Intrua Financial LLC raised its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 11.0% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,023 shares of the financial services provider’s stock after purchasing an additional 101 shares during the quarter. Intrua Financial LLC’s holdings in CME Group were worth $272,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Heartland Bank & Trust Co bought a new position in CME Group during the 1st quarter valued at $377,000. Catalyst Capital Advisors LLC boosted its stake in CME Group by 256.9% during the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider’s stock valued at $971,000 after purchasing an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. bought a new position in CME Group during the 1st quarter valued at $367,000. Fulcrum Equity Management bought a new position in CME Group during the 1st quarter valued at $258,000. Finally, AIA Group Ltd boosted its stake in CME Group by 17.8% during the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider’s stock valued at $4,416,000 after purchasing an additional 2,510 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Price Performance

CME opened at $262.30 on Friday. The stock has a fifty day moving average of $273.60 and a 200-day moving average of $270.29. The firm has a market capitalization of $94.53 billion, a P/E ratio of 25.39, a PEG ratio of 4.75 and a beta of 0.43. CME Group Inc. has a 12-month low of $212.38 and a 12-month high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.56 earnings per share. Equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be issued a $1.25 dividend. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio is presently 48.40%.

Insiders Place Their Bets

In other news, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider owned 17,440 shares in the company, valued at $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director William R. Shepard bought 256 shares of CME Group stock in a transaction dated Wednesday, June 25th. The stock was acquired at an average price of $270.53 per share, with a total value of $69,255.68. Following the acquisition, the director directly owned 258,196 shares of the company’s stock, valued at approximately $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on CME shares. Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Oppenheimer raised their price objective on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research note on Thursday, July 24th. Citigroup raised their price objective on CME Group from $265.00 to $275.00 and gave the stock a “neutral” rating in a research note on Thursday, July 3rd. UBS Group reduced their price objective on CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research note on Monday, September 8th. Finally, Erste Group Bank lowered CME Group from a “strong-buy” rating to a “hold” rating in a research note on Saturday, May 24th. Four analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $260.60.

Read Our Latest Stock Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.